Patent · US Expired

Pyrimidinyl compounds for treatment of central nervous system disorders

US6555684B2 · kind B2 · utility

13Cited by

8References

7Claims

0Family size

Assignee

Targacept, Inc. · US

Inventors

William Scott Caldwell · Winston-Salem, US
Gary Maurice Dull · Lewisville, US
Grayland Page Dobson · Winston-Salem, US

Key dates

Filing date	Oct 9, 2001
Grant date	Apr 29, 2003
Priority date	—
Expiry date	Oct 9, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Patients susceptible to or suffering from central nervous system disorders are treated by administering effective amounts of aryl substituted aliphatic amine compounds, aryl substituted olefinic amine compounds or aryl substituted acetylenic amine compounds. A representative compound is (E)-N-methyl-5-(3-pyridinyl)-4-penten-2-amine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.